Sabaa International Company for Pharmaceutical and Chemical Industry's latest marketcap:
As of 08/14/2025, Sabaa International Company for Pharmaceutical and Chemical Industry's market capitalization has reached $20.39 M. According to our data, Sabaa International Company for Pharmaceutical and Chemical Industry is the 36648th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 20.39 M |
| Revenue (ttm) | 680,976.83 |
| Net Income (ttm) | -134,247.99 |
| Shares Out | 250 M |
| EPS (ttm) | 0 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/14/2025 |
Sabaa International Company for Pharmaceutical and Chemical Industry's yearly market capitalization.
| Date | Market Cap | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 08/14/2025 | 985 M | $20.39 M | 181.82% | 36648 |
| 12/31/2024 | 330 M | $6.33 M | 65.41% | 40004 |
| 12/31/2023 | 199.5 M | $6.35 M | -29% | 38870 |
| 12/29/2022 | 281 M | $11.22 M | 5.05% | 35480 |
| 12/30/2021 | 267.5 M | $16.91 M | 18.13% | 33495 |
| 12/31/2020 | 226.44 M | $14.29 M | 17.63% | 30875 |
| 12/31/2019 | 192.5 M | $11.91 M | 63.89% | 28317 |
| 12/31/2018 | 117.46 M | $6.51 M | -33.72% | 29083 |
| 12/31/2017 | 177.21 M | $9.86 M | 73.74% | 27670 |
| 12/29/2016 | 102 M | $5.46 M | -27.92% | 26686 |
Company Profile
About Sabaa International Company
Sabaa International Company for Pharmaceutical and Chemical Industry is a leading manufacturer and distributor of generic medicines in Egypt. Established in 2000 and headquartered in Cairo, the company specializes in a diverse range of pharmaceutical products.
Key Products & Services
- Hard Gelatin Capsules: Including Acitretin and other formulations.
- Film-Coated Tablets: Such as Saboctic, Topiramate, and Tolterodine.
- Tablets: Including Claudol and Flamogen E.C.T.
- Over-the-Counter (OTC) Products: A variety of non-prescription medicines.
- Food Supplements & Veterinary Products: Supporting health and wellness.
- Medicine Trials: Clinical research and testing services.
With a commitment to quality and innovation, Sabaa International plays a vital role in Egypt's pharmaceutical sector.
Frequently Asked Questions
-
What is Sabaa International Company for Pharmaceutical and Chemical Industry's (EGX-SIPC) current market cap?As of 08/14/2025, Sabaa International Company for Pharmaceutical and Chemical Industry (including the parent company, if applicable) has an estimated market capitalization of $20.39 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Sabaa International Company for Pharmaceutical and Chemical Industry (EGX-SIPC) rank globally by market cap?Sabaa International Company for Pharmaceutical and Chemical Industry global market capitalization ranking is approximately 36648 as of 08/14/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.